Literature DB >> 17638829

Botulinum toxin for the treatment of acute-onset concomitant esotropia in Chiari I malformation.

Alison Y Firth, John P Burke.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17638829      PMCID: PMC1954814          DOI: 10.1136/bjo.2006.111104

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Acute comitant esotropia in Chiari 1 malformation.

Authors:  R K Imes; T A Quinn
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

Review 2.  Treatment of acute comitant esotropia in Chiari I malformation.

Authors:  C L Weeks; L M Hamed
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  Does posterior fossa decompression improve oculomotor and vestibulo-ocular manifestations in Chiari 1 malformation?

Authors:  W A Liebenberg; H Georges; A K Demetriades; C Hardwidge
Journal:  Acta Neurochir (Wien)       Date:  2005-08-29       Impact factor: 2.216

4.  Acquired esotropia. A manifestation of Chiari I malformation.

Authors:  M Passo; W T Shults; T Talbot; E A Palmer
Journal:  J Clin Neuroophthalmol       Date:  1984-09

Review 5.  Resolution of acute acquired comitant esotropia after suboccipital decompression for Chiari I malformation.

Authors:  Sabine Defoort-Dhellemmes; Eric Denion; Carl F Arndt; Isabelle Bouvet-Drumare; Jean-Claude Hache; Patrick Dhellemmes
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

6.  Chiari 1 malformation presenting as strabismus.

Authors:  Lionel Kowal; Claudia Yahalom; Neil H Shuey
Journal:  Binocul Vis Strabismus Q       Date:  2006

7.  The role of botulinum toxin A in acute-onset esotropia.

Authors:  E L Dawson; W E Marshman; G G Adams
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

  7 in total
  1 in total

1.  Botulinum toxin for the treatment of cyclic esotropia in a child with Chiari type I malformation.

Authors:  Inae E Jang; John A Davis; K David Epley; Michelle T Cabrera
Journal:  J AAPOS       Date:  2020-04-07       Impact factor: 1.220

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.